FCS Announcement

We are collecting anonymised information on patients with familial chylomicronaemia syndrome (FCS)/multifactorial chylomicronaemia syndrome (MCS) as a service evaluation & quality improvement project. The project aims to improve understanding of natural history of FCS and to validate the use of FCS scoring algorithm. The project is approved by Manchester University …

Continue reading


Posticipato 3-4 Settembre 2020 1st JOINT MEETING WITH THE NATIONAL ASSOCIATION FOR FAMILIAL HYPERCHOLESTEROLAEMIA (A.N.I.F. Italia) TWENTY YEARS CELEBRATION Advanced Course on Clinical Lipidology, Metabolicdisorders, and atherosclerosis preventionFocus on novel drugs and therapeutic apheresis Corso Avanzato di Lipidologia Clinica, Disturbi del metabolismoe prevenzione dell’aterosclerosiFocus sui nuovi farmaci e sull’aferesi terapeutica …

Continue reading

E-ISFA 2020 Announcement

3rd Congress of the European Group – International Society for Apheresis (E-ISFA) Dresden, March 19 to 21, 2020 Congress Topics Recent progress in lipoprotein apheresis Homozygous familial hypercholesterolemia Lipoprotein(a) Competition with drugs Plasma exchange Immunoadsorption – indications, results, future perspectives Experience with extracorporeal therapy in children and during pregnancy Apheresis Registries …

Continue reading

LipidClub 2019

14th Lipid Club and Therapeutic Apheresis 2019 Udine, 30-31 Maggio 2019 ADVANCED COURSE ON CLINICAL LIPIDOLOGY, METABOLIC DISORDERS AND THERAPEUTIC APHERESIS PROGRAMMA DEFINITIVO La notizia su PrimaPaginaNews  

Ipercolesterolemia familiare: una “Call to Action” globale per migliorare la diagnosi

La federazione FH Europe, riunita a Parigi per il suo meeting annuale, contribuirà alla revisione delle politiche mondiali sulla patologia in occasione del Congresso Mondiale di Cardiologia, il mese prossimo a Dubai Parigi – Un’altra generazione di pazienti con ipercolesterolemia familiare (FH) non può essere lasciata indifesa, in balia delle malattie cardiache. Secondo …

Continue reading